Research ArticleCancer

ARID1A mutation plus CXCL13 expression act as combinatorial biomarkers to predict responses to immune checkpoint therapy in mUCC

See allHide authors and affiliations

Science Translational Medicine  17 Jun 2020:
Vol. 12, Issue 548, eabc4220
DOI: 10.1126/scitranslmed.abc4220

Log in to view PDF

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine